🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

11 recruiting trials

for Cutaneous Lupus Erythematosus(CLE)

Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus NCT01510067n/a2 sites📍 Philadelphia📍 Dallas University of Pennsylvania A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus NCT07260877Phase 234 sites📍 Beverly Hills📍 Clearwater📍 DeBary Ventus Therapeutics U.S., Inc. · Tests: VENT-03, Placebo A Study of Quinacrine in Participants With Cutaneous Lupus Erythematosus NCT07694336Phase 21 site📍 Philadelphia Victoria Werth · Tests: Quinacrine Hydrochloride, Placebo A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease NCT07332481Phase 360 sites📍 Los Angeles📍 Thousand Oaks📍 Cooper City EMD Serono Research & Development Institute, Inc. · Tests: Enpatoran, Placebo, Standard of care (SoC) A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2) NCT07355218Phase 357 sites📍 Upland📍 DeBary📍 Fort Lauderdale EMD Serono Research & Development Institute, Inc. · Tests: Enpatoran, Placebo, Standard of care (SoC) Evaluate the Efficacy and Safety of ICP-488 in Subjects With Cutaneous Lupus Erythematosus (CLE) Double-blind Study NCT07440537Phase 227 sites📍 Hefei📍 Beijing📍 Beijing Beijing InnoCare Pharma Tech Co., Ltd. · Tests: ICP-488 Tablets, ICP-488 Tablets, ICP-488 Placebo A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants NCT06625671Phase 1, Phase 27 sites📍 La Palma📍 Clearwater📍 Orlando DualityBio Inc. · Tests: DB-2304, Placebo, Prednisone Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease NCT07455578Phase 12 sites📍 Charlestown📍 Birtinya Seismic Therapeutic AU Pty Ltd · Tests: S-4321 Research Accelerated by You Lupus Registry NCT06927219n/a1 site📍 Washington D.C. Lupus Foundation of America A Study on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SHR-7012 in Healthy Adults NCT07749651Phase 11 site📍 Hangzhou Guangdong Hengrui Pharmaceutical Co., Ltd · Tests: SHR-7012 injection ; placebo, SHR-7012 injection ; placebo, SHR-7012 injection ; placebo, SHR-7012 injection ; placebo,… Cutaneous Lupus Registry NCT01266915n/a1 site📍 Dallas University of Texas Southwestern Medical Center
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy